The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis

被引:136
作者
McFarlane, PA
Bayoumi, AM
Pierratos, A
Redelmeier, DA
机构
[1] Univ Toronto, St Michaels Hosp, Dept Med,Inner City Hlth Res Unit, Home Dialysis Clin, Toronto, ON M5C 2T2, Canada
[2] Humber River Reg Hosp, Toronto, ON, Canada
[3] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
关键词
economic analysis; hemodialysis; home; prospective studies; resource allocation;
D O I
10.1046/j.1523-1755.2003.00157.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Home nocturnal hemodialysis is an intensive form of hemodialysis, where patients perform their treatments at home for about 7 hours approximately 6 nights a week. Compared with in-center conventional hemodialysis, home nocturnal hemodialysis has been shown to improve physiologic parameters and reduce health care costs; however, the effects on quality of life and cost utility are less clear. We hypothesized that individuals performing home nocturnal hemodialysis would have a higher quality of life and superior cost utility than in-center hemodialysis patients. Methods. Home nocturnal hemodialysis patients and a demographically similar group of in-center hemodialysis patients from a hospital without a home hemodialysis program underwent computer-assisted interviews to assess their utility score for current health by the standard gamble method. Results. Nineteen in-center hemodialysis and 24 home nocturnal hemodialysis patients were interviewed. Mean annual costs for home nocturnal hemodialysis were about $10,000 lower for home nocturnal hemodialysis ($55,139 +/-$7651 for home nocturnal hemodialysis vs. $66,367 +/-$17,502 for in-center hemodialysis, P = 0.03). Home nocturnal hemodialysis was associated with a higher utility score than in-center hemodialysis (0.77 +/- 0.23 vs. 0.53 +/- 0.35, P = 0.03). The cost utility for home nocturnal hemodialysis was $71,443/quality-adjusted life-year (QALY), while for in-center hemodialysis it was $125,845/QALY. Home nocturnal hemodialysis was the dominant strategy, with an incremental cost-effectiveness ratio (ICER) of -$45,932. The 95% CI for the ICER, and 2500 bootstrap iterations of the ICER all fell below the cost-effectiveness ceiling of $50,000. The net monetary benefit of home nocturnal hemodialysis ranged from $11,227 to $35,669. Conclusion. Home nocturnal hemodialysis is associated with a higher quality of life and a superior cost utility when compared to in-center hemodialysis.
引用
收藏
页码:1004 / 1011
页数:8
相关论文
共 49 条
[31]  
2-V
[32]   Cost savings of home nocturnal versus conventional in-center hemodialysis [J].
McFarlane, PA ;
Pierratos, A ;
Redelmeier, DA .
KIDNEY INTERNATIONAL, 2002, 62 (06) :2216-2222
[33]   Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis [J].
Mucsi, I ;
Hercz, G ;
Uldall, R ;
Ouwendyk, M ;
Francoeur, R ;
Pierratos, A .
KIDNEY INTERNATIONAL, 1998, 53 (05) :1399-1404
[34]   Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: A pilot study [J].
O'Sullivan, DA ;
McCarthy, JT ;
Kumar, R ;
Williams, AW .
MAYO CLINIC PROCEEDINGS, 1998, 73 (11) :1035-1045
[35]   IN SEARCH OF POWER AND SIGNIFICANCE - ISSUES IN THE DESIGN AND ANALYSIS OF STOCHASTIC COST-EFFECTIVENESS STUDIES IN HEALTH-CARE [J].
OBRIEN, BJ ;
DRUMMOND, MF ;
LABELLE, RJ ;
WILLAN, A .
MEDICAL CARE, 1994, 32 (02) :150-163
[36]  
Park IH, 1996, TRANSPLANT P, V28, P1937
[37]  
Pierratos A, 1999, CAN MED ASSOC J, V161, P1137
[38]   Daily hemodialysis: an update [J].
Pierratos, A .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2002, 11 (02) :165-171
[39]  
Pierratos A, 2001, INT J ARTIF ORGANS, V24, P1
[40]  
Pierratos A, 1998, J AM SOC NEPHROL, V9, P859